Management of the hospitalized patient with Parkinson's disease: Current state of the field and need for guidelines

被引:88
作者
Aminoff, Michael J. [1 ]
Christine, Chad W. [1 ]
Friedman, Joseph H. [2 ]
Chou, Kelvin L. [3 ]
Lyons, Kelly E. [4 ]
Pahwa, Rajesh [4 ]
Bloem, Bastian R. [5 ]
Parashos, Sotirios A. [6 ]
Price, Catherine C. [7 ]
Malaty, Irene A. [7 ]
Iansek, Robert [8 ]
Bodis-Wollner, Ivan [9 ]
Suchowersky, Oksana [10 ]
Oertel, Wolfgang H. [11 ]
Zamudio, Jorge
Oberdorf, Joyce
Schmidt, Peter
Okun, Michael S. [7 ]
机构
[1] Univ Calif San Francisco, Natl Parkinson Fdn, Ctr Excellence, Dept Neurol, San Francisco, CA 94143 USA
[2] Brown Univ, Butler Hosp, Alpert Med Sch, Dept Neurol, Providence, RI 02912 USA
[3] Univ Michigan, Dept Neurol & Neurosurg, Ann Arbor, MI 48109 USA
[4] Univ Kansas, Med Ctr, Parkinsons Dis & Movement Disorder Ctr, Natl Parkinson Fdn,Ctr Excellence, Lawrence, KS 66045 USA
[5] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Neurol, Natl Parkinson Fdn,Ctr Excellence, Nijmegen, Netherlands
[6] Natl Parkinson Fdn, Ctr Excellence, Struthers Parkinsons Ctr, Miami, FL USA
[7] Univ Florida, Movement Disorders Ctr, Natl Parkinson Fdn, Ctr Excellence, Gainesville, FL 32611 USA
[8] So Hlth, Clin Res Ctr Movement Disorders & Gait, Ctr Excellence, Natl Parkinson Fdn, Melbourne, Vic, Australia
[9] SUNY, Parkinsons Dis & Related Disorders Clin, Downstate Med Ctr, Natl Parkinson Fdn,Ctr Excellence, New York, NY USA
[10] Univ Calgary, Dept Clin Neurosci, Movement Disorders Program, Natl Parkinson Fdn,Ctr Excellence, Calgary, AB T2N 1N4, Canada
[11] Philipps Univ, Dept Neurol, Ctr Excellence, Natl Parkinson Fdn, Marburg, Germany
关键词
Complications; Surgery; Perioperative; Fall; Fracture; Confusion; Medication; PERIOPERATIVE RISK PROFILE; DRUG-INDUCED PSYCHOSIS; QUALITY-OF-LIFE; ELDERLY-PATIENTS; VOLUNTARY COUGH; DOUBLE-BLIND; CLOZAPINE; QUETIAPINE; DEPRESSION; SWALLOW;
D O I
10.1016/j.parkreldis.2010.11.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To review the literature and to identify practice gaps in the management of the hospitalized Parkinson's disease (PD) patient. Background: Patients with PD are admitted to hospitals at higher rates, and frequently have longer hospital stays than the general population. Little is known about outpatient interventions that might reduce the need for hospitalization and also reduce hospital-related complications. Methods: A literature review was performed on PubMed about hospitalization and PD between 1970 and 2010. In addition, in press peer-reviewed papers or published abstracts known to the authors were included. Information was reviewed by a National Parkinson Foundation workgroup and a narrative review article was generated. Results: Motor disturbances in PD are believed to be a causal factor in the higher rates of admissions and complications. However, other conditions are commonly recorded as the primary reason for hospitalization including motor complications, reduced mobility, lack of compliance, inappropriate use of neuroleptics, falls, fractures, pneumonia, and other important medical problems. There are many relevant issues related to hospitalization in PD. Medications, dosages and specific dosage schedules are critical. Staff training regarding medications and medication management may help to avoid complications, particularly those related to reduced mobility, and aspiration pneumonia. Treatment of infections and a return to early mobility is also critical to management. Conclusions: Educational programs, recommendations, and guidelines are needed to better train interdisciplinary teams in the management of the PD patient. These initiatives have the potential for both cost savings and improved outcomes from a preventative and a hospital management standpoint. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 83 条
[1]  
Aarsland Dag, 2008, Tidsskr Nor Laegeforen, V128, P2072
[2]   The Priamo Study: A Multicenter Assessment of Nonmotor Symptoms and Their Impact on Quality of Life in Parkinson's Disease [J].
Barone, Paolo ;
Antonini, Angelo ;
Colosimo, Carlo ;
Marconi, Roberto ;
Morgante, Letterio ;
Avarello, Tania P. ;
Bottacchi, Eugenio ;
Cannas, Antonino ;
Ceravolo, Gabriella ;
Ceravolo, Roberto ;
Cicarelli, Giulio ;
Gaglio, Roberto M. ;
Giglia, Rosa M. ;
Iemolo, Francesco ;
Manfredi, Michela ;
Meco, Giuseppe ;
Nicoletti, Alessandra ;
Pederzoli, Massimo ;
Petrone, Alfredo ;
Pisani, Antonio ;
Ponfieri, Francesco E. ;
Quatrale, Rocco ;
Ramat, Silvia ;
Scala, Rosanna ;
Volpe, Giuseppe ;
Zappulla, Salvatore ;
Bentivoglio, Anna Rita ;
Stocchi, Fabrizio ;
Trianni, Giorgio ;
Del Dotto, Paolo .
MOVEMENT DISORDERS, 2009, 24 (11) :1641-1649
[3]   DIAGNOSIS AND TREATMENT OF PARKINSONS-DISEASE [J].
CALNE, DB .
HOSPITAL PRACTICE, 1995, 30 (01) :83-&
[4]   Malignant dopaminergic syndrome [J].
Cansino, MDA ;
García, JLZ ;
Malagón, MJV ;
Jiménez, FR .
MEDICINA CLINICA, 2004, 122 (12) :477-477
[5]  
Cervo FA, 2006, GERIATRICS, V61, P30
[6]   Rivastigmine in Parkinson's disease dementia [J].
Chitnis, Shilpa ;
Rao, Jayaraman .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (08) :941-955
[7]  
CHOU K, 2007, 5 FREQUENTLY ASKED Q, P7
[8]   Parkinson's disease patients who fracture their neck of femur: A review of outcome [J].
Clubb, V. J. ;
Clubb, S. E. ;
Buckley, S. .
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2006, 37 (10) :929-934
[9]   Medical healthcare use in Parkinson's disease: survey in a cohort of ambulatory patients in Italy [J].
Cosentino, M ;
Martignoni, E ;
Michielotto, D ;
Calandrella, D ;
Riboldazzi, G ;
Pacchetti, C ;
Frigo, G ;
Nappi, G ;
Lecchini, S .
BMC HEALTH SERVICES RESEARCH, 2005, 5 (1)
[10]   Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia [J].
Darreh-Shori, Taher ;
Jelic, Vesna .
EXPERT OPINION ON DRUG SAFETY, 2010, 9 (01) :167-176